Key points are not available for this paper at this time.
Senescent and damaged mitochondria undergo selective mitophagic elimination through mechanisms requiring two Parkinson's disease factors, the mitochondrial kinase PINK1 (PTEN-induced putative kinase protein 1; PTEN is phosphatase and tensin homolog) and the cytosolic ubiquitin ligase Parkin. The nature of the PINK-Parkin interaction and the identity of key factors directing Parkin to damaged mitochondria are unknown. We show that the mitochondrial outer membrane guanosine triphosphatase mitofusin (Mfn) 2 mediates Parkin recruitment to damaged mitochondria. Parkin bound to Mfn2 in a PINK1-dependent manner; PINK1 phosphorylated Mfn2 and promoted its Parkin-mediated ubiqitination. Ablation of Mfn2 in mouse cardiac myocytes prevented depolarization-induced translocation of Parkin to the mitochondria and suppressed mitophagy. Accumulation of morphologically and functionally abnormal mitochondria induced respiratory dysfunction in Mfn2-deficient mouse embryonic fibroblasts and cardiomyocytes and in Parkin-deficient Drosophila heart tubes, causing dilated cardiomyopathy. Thus, Mfn2 functions as a mitochondrial receptor for Parkin and is required for quality control of cardiac mitochondria.
Building similarity graph...
Analyzing shared references across papers
Loading...
Yun Chen
Yale University
Gerald W. Dorn
Heart Failure / Cardiomyopathy
Science
Washington University in St. Louis
Building similarity graph...
Analyzing shared references across papers
Loading...
Chen et al. (Thu,) studied this question.
synapsesocial.com/papers/69daa3c1a6045d71bfa3d52c — DOI: https://doi.org/10.1126/science.1231031
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: